Lupin informs about press release

17 Mar 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, receipt of tentative approval from the U.S. FDA for the Company’s Abbreviated New Drug Application for Amifampridine Tablets, 10 mg.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2091.70 -21.25 (-1.01%)
29-Dec-2025 13:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1723.10
Dr. Reddys Lab 1265.75
Cipla 1497.70
Zydus Lifesciences 904.50
Lupin 2091.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×